aluates Reports

$ 0.0

Automative

Global Influenza Subunit Vaccine Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-34O16627

BUY CHAPTERS

Global Influenza Subunit Vaccine Market Research Report 2024

Code: QYRE-Auto-34O16627

Report

April 2024

Pages:67

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Seqirus

Ab&B BIO-TECH

Zhongyianke Biology

Influenza Subunit Vaccine Market

Influenza subunit vaccine is a type of vaccine used to prevent influenza. It contains specific protein subunits of the influenza virus, usually the influenza virus hemagglutinin and neuraminidase. These subunits stimulate the body's immune system to produce antibodies that provide protection when infected with the influenza virus.

The global Influenza Subunit Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Influenza Subunit Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Influenza Subunit Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Influenza Subunit Vaccine include Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza Subunit Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Subunit Vaccine.

The Influenza Subunit Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Influenza Subunit Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Influenza Subunit Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Influenza Subunit Vaccine Market Report

Report Metric	Details
Report Name	Influenza Subunit Vaccine Market
Segment by Type	Trivalent Vaccines Tetravalent Vaccine
Segment by Application	Aldult Child
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Subunit Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Subunit Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Influenza Subunit Vaccine Market report?

Ans: The main players in the Influenza Subunit Vaccine Market are Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology

What are the Application segmentation covered in the Influenza Subunit Vaccine Market report?

Ans: The Applications covered in the Influenza Subunit Vaccine Market report are Aldult, Child

What are the Type segmentation covered in the Influenza Subunit Vaccine Market report?

Ans: The Types covered in the Influenza Subunit Vaccine Market report are Trivalent Vaccines, Tetravalent Vaccine

1 Influenza Subunit Vaccine Market Overview

1.1 Product Definition

1.2 Influenza Subunit Vaccine by Type

1.2.1 Global Influenza Subunit Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Trivalent Vaccines

1.2.3 Tetravalent Vaccine

1.3 Influenza Subunit Vaccine by Application

1.3.1 Global Influenza Subunit Vaccine Market Value by Application (2024-2030)

1.3.2 Aldult

1.3.3 Child

1.4 Global Influenza Subunit Vaccine Market Size Estimates and Forecasts

1.4.1 Global Influenza Subunit Vaccine Revenue 2019-2030

1.4.2 Global Influenza Subunit Vaccine Sales 2019-2030

1.4.3 Global Influenza Subunit Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Influenza Subunit Vaccine Market Competition by Manufacturers

2.1 Global Influenza Subunit Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Influenza Subunit Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Influenza Subunit Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Influenza Subunit Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Influenza Subunit Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Influenza Subunit Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Influenza Subunit Vaccine, Date of Enter into This Industry

2.8 Global Influenza Subunit Vaccine Market Competitive Situation and Trends

2.8.1 Global Influenza Subunit Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Influenza Subunit Vaccine Players Market Share by Revenue

2.8.3 Global Influenza Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Influenza Subunit Vaccine Market Scenario by Region

3.1 Global Influenza Subunit Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Influenza Subunit Vaccine Sales by Region: 2019-2030

3.2.1 Global Influenza Subunit Vaccine Sales by Region: 2019-2024

3.2.2 Global Influenza Subunit Vaccine Sales by Region: 2025-2030

3.3 Global Influenza Subunit Vaccine Revenue by Region: 2019-2030

3.3.1 Global Influenza Subunit Vaccine Revenue by Region: 2019-2024

3.3.2 Global Influenza Subunit Vaccine Revenue by Region: 2025-2030

3.4 North America Influenza Subunit Vaccine Market Facts & Figures by Country

3.4.1 North America Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Influenza Subunit Vaccine Sales by Country (2019-2030)

3.4.3 North America Influenza Subunit Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Influenza Subunit Vaccine Market Facts & Figures by Country

3.5.1 Europe Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Influenza Subunit Vaccine Sales by Country (2019-2030)

3.5.3 Europe Influenza Subunit Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Influenza Subunit Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Influenza Subunit Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Influenza Subunit Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific Influenza Subunit Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Influenza Subunit Vaccine Market Facts & Figures by Country

3.7.1 Latin America Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Influenza Subunit Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Influenza Subunit Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Influenza Subunit Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Influenza Subunit Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Influenza Subunit Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Influenza Subunit Vaccine Sales by Type (2019-2030)

4.1.1 Global Influenza Subunit Vaccine Sales by Type (2019-2024)

4.1.2 Global Influenza Subunit Vaccine Sales by Type (2025-2030)

4.1.3 Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Influenza Subunit Vaccine Revenue by Type (2019-2030)

4.2.1 Global Influenza Subunit Vaccine Revenue by Type (2019-2024)

4.2.2 Global Influenza Subunit Vaccine Revenue by Type (2025-2030)

4.2.3 Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Influenza Subunit Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Influenza Subunit Vaccine Sales by Application (2019-2030)

5.1.1 Global Influenza Subunit Vaccine Sales by Application (2019-2024)

5.1.2 Global Influenza Subunit Vaccine Sales by Application (2025-2030)

5.1.3 Global Influenza Subunit Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Influenza Subunit Vaccine Revenue by Application (2019-2030)

5.2.1 Global Influenza Subunit Vaccine Revenue by Application (2019-2024)

5.2.2 Global Influenza Subunit Vaccine Revenue by Application (2025-2030)

5.2.3 Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Influenza Subunit Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Ab&B BIO-TECH

6.1.1 Ab&B BIO-TECH Company Information

6.1.2 Ab&B BIO-TECH Description and Business Overview

6.1.3 Ab&B BIO-TECH Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolio

6.1.5 Ab&B BIO-TECH Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sanofi Influenza Subunit Vaccine Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 Seqirus, Inc

6.3.1 Seqirus, Inc Company Information

6.3.2 Seqirus, Inc Description and Business Overview

6.3.3 Seqirus, Inc Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Seqirus, Inc Influenza Subunit Vaccine Product Portfolio

6.3.5 Seqirus, Inc Recent Developments/Updates

6.4 Zhongyianke Biology

6.4.1 Zhongyianke Biology Company Information

6.4.2 Zhongyianke Biology Description and Business Overview

6.4.3 Zhongyianke Biology Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Zhongyianke Biology Influenza Subunit Vaccine Product Portfolio

6.4.5 Zhongyianke Biology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Influenza Subunit Vaccine Industry Chain Analysis

7.2 Influenza Subunit Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Influenza Subunit Vaccine Production Mode & Process

7.4 Influenza Subunit Vaccine Sales and Marketing

7.4.1 Influenza Subunit Vaccine Sales Channels

7.4.2 Influenza Subunit Vaccine Distributors

7.5 Influenza Subunit Vaccine Customers

8 Influenza Subunit Vaccine Market Dynamics

8.1 Influenza Subunit Vaccine Industry Trends

8.2 Influenza Subunit Vaccine Market Drivers

8.3 Influenza Subunit Vaccine Market Challenges

8.4 Influenza Subunit Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

Seqirus

Ab&B BIO-TECH

Zhongyianke Biology

List of Tables

Table 1. Global Influenza Subunit Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Influenza Subunit Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Influenza Subunit Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Influenza Subunit Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Influenza Subunit Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Influenza Subunit Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Influenza Subunit Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Influenza Subunit Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Influenza Subunit Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Influenza Subunit Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Influenza Subunit Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Influenza Subunit Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Influenza Subunit Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Subunit Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Influenza Subunit Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Influenza Subunit Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Influenza Subunit Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Influenza Subunit Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Influenza Subunit Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Influenza Subunit Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Influenza Subunit Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Influenza Subunit Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Influenza Subunit Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Influenza Subunit Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Influenza Subunit Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Influenza Subunit Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Influenza Subunit Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Influenza Subunit Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Influenza Subunit Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Influenza Subunit Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Influenza Subunit Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Influenza Subunit Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Influenza Subunit Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Influenza Subunit Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Influenza Subunit Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Influenza Subunit Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Influenza Subunit Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Influenza Subunit Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Influenza Subunit Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Influenza Subunit Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Influenza Subunit Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Influenza Subunit Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Influenza Subunit Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Influenza Subunit Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Influenza Subunit Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Ab&B BIO-TECH Company Information

Table 71. Ab&B BIO-TECH Description and Business Overview

Table 72. Ab&B BIO-TECH Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Ab&B BIO-TECH Influenza Subunit Vaccine Product

Table 74. Ab&B BIO-TECH Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Sanofi Influenza Subunit Vaccine Product

Table 79. Sanofi Recent Developments/Updates

Table 80. Seqirus, Inc Company Information

Table 81. Seqirus, Inc Description and Business Overview

Table 82. Seqirus, Inc Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Seqirus, Inc Influenza Subunit Vaccine Product

Table 84. Seqirus, Inc Recent Developments/Updates

Table 85. Zhongyianke Biology Company Information

Table 86. Zhongyianke Biology Description and Business Overview

Table 87. Zhongyianke Biology Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Zhongyianke Biology Influenza Subunit Vaccine Product

Table 89. Zhongyianke Biology Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Influenza Subunit Vaccine Distributors List

Table 93. Influenza Subunit Vaccine Customers List

Table 94. Influenza Subunit Vaccine Market Trends

Table 95. Influenza Subunit Vaccine Market Drivers

Table 96. Influenza Subunit Vaccine Market Challenges

Table 97. Influenza Subunit Vaccine Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Influenza Subunit Vaccine

Figure 2. Global Influenza Subunit Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Influenza Subunit Vaccine Market Share by Type: 2023 & 2030

Figure 4. Trivalent Vaccines Product Picture

Figure 5. Tetravalent Vaccine Product Picture

Figure 6. Global Influenza Subunit Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Influenza Subunit Vaccine Market Share by Application: 2023 & 2030

Figure 8. Aldult

Figure 9. Child

Figure 10. Global Influenza Subunit Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Influenza Subunit Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Influenza Subunit Vaccine Sales (2019-2030) & (K Units)

Figure 13. Global Influenza Subunit Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 14. Influenza Subunit Vaccine Report Years Considered

Figure 15. Influenza Subunit Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Influenza Subunit Vaccine Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest Influenza Subunit Vaccine Players: Market Share by Revenue in Influenza Subunit Vaccine in 2023

Figure 18. Influenza Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global Influenza Subunit Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Influenza Subunit Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Influenza Subunit Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Influenza Subunit Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Influenza Subunit Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Mexico Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Brazil Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Argentina Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Colombia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East and Africa Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Influenza Subunit Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Influenza Subunit Vaccine by Type (2019-2030)

Figure 51. Global Revenue Market Share of Influenza Subunit Vaccine by Type (2019-2030)

Figure 52. Global Influenza Subunit Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Influenza Subunit Vaccine by Application (2019-2030)

Figure 54. Global Revenue Market Share of Influenza Subunit Vaccine by Application (2019-2030)

Figure 55. Global Influenza Subunit Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 56. Influenza Subunit Vaccine Value Chain

Figure 57. Influenza Subunit Vaccine Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Global Inactivated Poultry Vaccine Market Research Report 2025

Global Flu Vaccination Market Research Report 2025

Global Flu Vaccine Market Insights Forecast to 2030

Global Human Injection Flu Vaccine Market Research Report 2025

Global Injection Flu Shot Market Research Report 2025

Global Flu RNA Vaccines Market Research Report 2025

Global Recombinant Influenza Vaccine Market Research Report 2024

Children Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Influenza Vaccine Split Virion Inactivated Quadrivalent Market Research Report 2024

Global Flu Prevention Market Research Report 2024

Global Egg free Flu Vaccine Market Research Report 2024

Global Viral Vector Vaccine for Humans Market Research Report 2024

Global Trivalent Split Influenza Vaccine Market Research Report 2025

Global Avian Influenza Vaccines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Travelers Vaccines Market Research Report 2025

Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacterial Vaccines for Humans Market Research Report 2024

Global Poultry Vaccines Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions